CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04139369
NCT04139369N/ACompleted

Study of DNA Methylation in Children and Adolescents With Type 1 Diabetes Mellitus

Aristotle University Of Thessaloniki·observational·Posted Oct 25, 2019·Updated Oct 25, 2019

In Brief

An observational study for Type 1 Diabetes Mellitus. Completed, enrolled 40 participants across 1 site.

Detailed Summary

Type 1 Diabetes Mellitus (T1DM) is a well-studied autoimmune disease resulting in insulin deficiency due to selective β-cell destruction. Epigenetics is a novel field of biology studying the inherited changes in deoxyribonucleic acid (DNA) expression which cannot be attributed to base sequence alteration. A relatively limited number of studies are published until now concerning T1DM in children and adolescents addressing epigenetics changes in DNA expression. The purpose of the present study is to analyze the methylation status of DNA within the promoter region of specific susceptibility genes such as Protein tyrosine phosphatase, non-receptor type 22 (PTPN-22), Insulin (INS) and Human leukocyte antigen G (HLA-G) genes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGreece
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 25, 2019
Enrollment StartMay 1, 2012
Primary CompletionMay 1, 2015
Study CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 6.7 years ago